Account
Yellophant Digital bags digital mandate for 1Rivet India
Mumbai: Yellophant Digital, an alliance of Merge Infinity Global, has acquired the digital mandate for 1Rivet India, a tech-based consultancy firm, headquartered in the USA.
The mandate includes entire social media responsibilities for the brand from ideation to execution. “The agency will manage the brand’s social media presence on platforms such as Instagram, Facebook, and LinkedIn. Yellophant Digital also plans on launching the brand on any new platform that can help the brand maximise its reach,” said the statement.
“We have engaged Yellophant Digital to manage our digital presence and we are happy with the way they’ve run the program so far,” said 1Rivet India CEO Harikrishna Nair. “The Yellophant Digital team is responsive and easy to do business with. It’s definitely worth having a conversation with them if you’re thinking of investing in your company’s social media presence.”
“We are thrilled to be working with 1Rivet India,” stated Yellophant Digital co-founder Preksha Seth. “There is so much commonality between us, especially a shared vision of what the organisation should communicate online. With both our teams being young and dynamic, it shall be an exciting collaboration.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
